Skip to content

Author

G. Giannelli

5 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Cost-effectiveness of an integrated lifestyle intervention for obesity in southern Italy: a model-based simulation of costs, health outcomes and gastrointestinal cancer burden

We assessed the cost-effectiveness of a publicly funded lifestyle programme (supervised exercise and nutritional counselling) for adults with obesity (BMI 30.0–34.9 kg/m 2 ) in Southern Italy and its projected effect on colorectal and hepatocellular cancer burden. A deterministic cohort state-transition (Markov-typ...

M. Polignano, Davide Guido, O. Rotolo et al. · 0 citations
Open access Oct 2026

Short-Term Changes in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Related Circulating Biomarkers Following a Very-Low Calorie Ketogenic Diet (VLCKD): A Paired Longitudinal Analysis

Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease worldwide. Its prevalence is constantly increasing, particularly among obese individuals. Lifestyle modifications remain the first-line intervention for the management and treatment of MASLD. The most w...

R. Tatoli, Rossella Donghia, P. L. Pesole et al. · 0 citations
Open access Oct 2026

Dietary Polyphenol Intake Inversely Associates with Fibrosis Scores in Individuals with MASLD

Background & aims. Plant-based dietary patterns, such as the Mediterranean diet, are considered protective against MASLD. The Mediterranean diet is rich in polyphenols (PP), plant-derived metabolites that exhibit anti-fibrotic effects in experimental models. This study aimed to evaluate the association between dietary...

C. Bonfiglio, M. N. Pastore, Manuela Siani et al. · 0 citations
Review Open access Sep 2026

Biomarker-Driven Strategies for Stromal Reprogramming in Pancreatic Ductal Adenocarcinoma

Evidence on stromal biomarkers with prognostic or predictive value, including tumor–stroma ratio, fibrosis burden, cancer-associated fibroblast states, extracellular matrix stiffness, vascular accessibility, and spatial immune features are summarized.

M. De Luca, Francesco Balestra, Giorgia Panzetta et al. · 0 citations
Open access Jul 2026

AMIUgraph: analysis and modeling of interactions for utility-driven benchmarking of graph-based models in healthcare.

AMIUGraph provides a clinically grounded and utility-driven benchmarking framework that jointly evaluates KGE and GNN models across multiple healthcare graph types and learning settings, and offers practical guidance for selecting graph-based models in medical decision-support systems.

P. Sorino, A. D. Bellis, Daniele Malitesta et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.